ARVN (Arvinas) Inventories, Raw Materials & Components: $0.00 Mil (As of Mar. 2026)


ARVN Arvinas Inc ARVN
70 GF Score
Price $8.31
GF Value $11.89
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Arvinas Inventories, Raw Materials & Components?

Arvinas ARVN +0.36% 70 Inventories, Raw Materials & Components is $0.00 Mil as of Mar. 2026. GuruFocus rates ARVN with a GF Score™ of 70/100 and a GF Value™ of $11.89 (Possible Value Trap). The stock has 6 warning signs investors should review.

Arvinas's inventories, raw materials & components for the quarter that ended in Mar. 2026 was $0.00 Mil.

Arvinas Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Arvinas's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arvinas Inventories, Raw Materials & Components Chart

Arvinas Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Arvinas Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ARVN
70GF Score
Arvinas Inc ARVN
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arvinas Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $0.00 Mil mean?
Arvinas (ARVN) has a Inventories, Raw Materials & Components of $0.00 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Arvinas and its competitors.
Is Arvinas' Inventories, Raw Materials & Components too high?
Arvinas' current Inventories, Raw Materials & Components is $0.00 Mil. Overall, Arvinas has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arvinas' Inventories, Raw Materials & Components compare to ZURA and KYTX?
Arvinas' Inventories, Raw Materials & Components of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Arvinas and its competitors. Arvinas's current Inventories, Raw Materials & Components is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvinas stock overvalued right now?
Based on GuruFocus' analysis, Arvinas (ARVN) is currently considered Possible Value Trap. The stock's GF Value™ is $11.89, compared to a current price of $8.31 — trading 30.1% below its estimated fair value. The current Inventories, Raw Materials & Components is $0.00 Mil. Arvinas' overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Arvinas (ARVN), the current Inventories, Raw Materials & Components is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arvinas (ARVN) Overvalued in 2026?

Based on GuruFocus' analysis, Arvinas stock appears to be undervalued. The current stock price of $8.31 is trading 30.1% below its estimated GF Value™ of $11.89. GuruFocus considers Arvinas to be Possible Value Trap.

Key valuation signals for ARVN:

  • Inventories, Raw Materials & Components: $0.00 Mil
  • GF Value™: $11.89 vs. price of $8.31 (30.1% below fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the ARVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arvinas Business Description

Address 395 Winchester Avenue, 5 Science Park, New Haven, CT, USA, 06511
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.
70GF Score

Get the complete analysis for ARVN

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.31
Price
$11.89
GF Value